{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:10:17Z","timestamp":1793419817172,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014219","name":"National Science Fund for Distinguished Young Scholars","doi-asserted-by":"publisher","award":["82225039"],"award-info":[{"award-number":["82225039"]}],"id":[{"id":"10.13039\/501100014219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2023YFC12509003"],"award-info":[{"award-number":["2023YFC12509003"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010909","name":"Excellent Young Scientists Fund","doi-asserted-by":"publisher","award":["82422063"],"award-info":[{"award-number":["82422063"]}],"id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203958"],"award-info":[{"award-number":["82203958"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Skin barrier dysfunction and immune activation are hallmarks of inflammatory skin diseases such as rosacea and psoriasis, suggesting shared pathogenic mechanisms. While barrier disruption may trigger or exacerbate skin inflammation, the precise underlying mechanisms remain unclear. Notably, epidermal barrier compromise leads to a marked increase in barrier alarmin expression. Among these, keratin 6A (KRT6A) plays a role in maintaining skin barrier integrity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We treated mouse skin and human keratinocytes, with and without KRT6A expression, with LL37\/TNF-\u03b1 and assessed the severity of inflammation. The specific mechanism by which KRT6A promotes skin inflammation was investigated using mass spectrometry and immunoprecipitation assays.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>KRT6A expression was elevated in lesional skin from patients and mouse models of rosacea and psoriasis. In mice with LL37-induced rosacea-like and imiquimod (IMQ)-induced psoriasis-like skin inflammation, KRT6A knockdown alleviated inflammation, whereas KRT6A overexpression exacerbated inflammatory responses. Mechanistically, KRT6A activated signal transducer and activator of transcription 3 (STAT3) and enhanced proinflammatory cytokine expression in keratinocytes by reducing Janus kinase 1 (JAK1) ubiquitination. This occurred through inhibition of ring finger protein 41 (RNF41)-mediated JAK1 binding.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our findings indicate that KRT6A expression increases following epidermal barrier disruption and contributes to exacerbated skin inflammation in disease conditions. Targeting KRT6A may represent a novel therapeutic approach for inflammatory skin diseases associated with epidermal dysfunction.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12929-025-01143-9","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T19:00:53Z","timestamp":1746817253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Keratin 6A promotes skin inflammation through JAK1-STAT3 activation in keratinocytes"],"prefix":"10.1186","volume":"32","author":[{"given":"Mengting","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"San","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0931-5562","authenticated-orcid":false,"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"issue":"10","key":"1143_CR1","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.jid.2020.02.025","volume":"140","author":"B Medgyesi","year":"2020","unstructured":"Medgyesi B, Dajnoki Z, B\u00e9ke G, G\u00e1sp\u00e1r K, Szab\u00f3 IL, Janka EA, et al. Rosacea is characterized by a profoundly diminished skin barrier. J Invest Dermatol. 2020;140(10):1938-50.e5.","journal-title":"J Invest Dermatol"},{"key":"1143_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10020359","author":"T Montero-Vilchez","year":"2021","unstructured":"Montero-Vilchez T, Segura-Fern\u00e1ndez-Nogueras MV, P\u00e9rez-Rodr\u00edguez I, Soler-Gongora M, Martinez-Lopez A, Fern\u00e1ndez-Gonz\u00e1lez A. Skin barrier function in psoriasis and atopic dermatitis: transepidermal water loss and temperature as useful tools to assess disease severity. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10020359.","journal-title":"J Clin Med"},{"issue":"2","key":"1143_CR3","first-page":"282","volume":"179","author":"L Gether","year":"2018","unstructured":"Gether L, Overgaard LK, Egeberg A. Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol. 2018;179(2):282\u20139.","journal-title":"Br J Dermatol"},{"key":"1143_CR4","volume":"369","author":"R Parisi","year":"2020","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ (Clinical Research ed). 2020;369: m1590.","journal-title":"BMJ (Clinical Research ed)"},{"issue":"11","key":"1143_CR5","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/exd.12251","volume":"22","author":"R Darlenski","year":"2013","unstructured":"Darlenski R, Kazandjieva J, Tsankov N, Fluhr JW. Acute irritant threshold correlates with barrier function, skin hydration and contact hypersensitivity in atopic dermatitis and rosacea. Exp Dermatol. 2013;22(11):752\u20133.","journal-title":"Exp Dermatol"},{"issue":"4","key":"1143_CR6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1365-2133.1995.tb02696.x","volume":"133","author":"IM Leigh","year":"1995","unstructured":"Leigh IM, Navsaria H, Purkis PE, McKay IA, Bowden PE, Riddle PN. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Br J Dermatol. 1995;133(4):501\u201311.","journal-title":"Br J Dermatol"},{"key":"1143_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061475","author":"A Rendon","year":"2019","unstructured":"Rendon A, Sch\u00e4kel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20061475.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1143_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41467-019-13756-4","volume":"11","author":"F Herster","year":"2020","unstructured":"Herster F, Bittner Z, Archer NK, Dickh\u00f6fer S, Eisel D, Eigenbrod T, et al. Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasis. Nat Commun. 2020;11(1):105.","journal-title":"Nat Commun"},{"key":"1143_CR9","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.151846","author":"A Mylonas","year":"2023","unstructured":"Mylonas A, Hawerkamp HC, Wang Y, Chen J, Messina F, Demaria O, et al. Type I IFNs link skin-associated dysbiotic commensal bacteria to pathogenic inflammation and angiogenesis in rosacea. JCI Insight. 2023. https:\/\/doi.org\/10.1172\/jci.insight.151846.","journal-title":"JCI Insight."},{"issue":"3","key":"1143_CR10","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jaci.2010.10.018","volume":"127","author":"A De Benedetto","year":"2011","unstructured":"De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C, et al. Tiht junction defects in patients with atopic dermatitis. J Allergy Clin Immunol. 2011;127(3):773-86.e1-7.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1143_CR11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.anai.2017.03.006","volume":"118","author":"SM Knox","year":"2017","unstructured":"Knox SM, Erwin EA, Mosser-Goldfarb JL, Scherzer R. Sensitization patterns among patients with atopic dermatitis evaluated in a large tertiary care pediatric center. Ann Allergy Asthma Immunol. 2017;118(5):645\u20137.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"8","key":"1143_CR12","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1172\/JCI1647","volume":"101","author":"JM Spergel","year":"1998","unstructured":"Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Investig. 1998;101(8):1614\u201322.","journal-title":"J Clin Investig"},{"issue":"1 Suppl","key":"1143_CR13","doi-asserted-by":"publisher","first-page":"44s","DOI":"10.1038\/jid.1983.12","volume":"80","author":"PM Elias","year":"1983","unstructured":"Elias PM. Epidermal lipids, barrier function, and desquamation. J Invest Dermatol. 1983;80(1 Suppl):44s-s49.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"1143_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1046\/j.1523-1747.1998.00318.x","volume":"111","author":"S Ekanayake-Mudiyanselage","year":"1998","unstructured":"Ekanayake-Mudiyanselage S, Aschauer H, Schmook FP, Jensen JM, Meingassner JG, Proksch E. Expression of epidermal keratins and the cornified envelope protein involucrin is influenced by permeability barrier disruption. J Invest Dermatol. 1998;111(3):517\u201323.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"1143_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.coi.2005.06.002","volume":"17","author":"JJ Oppenheim","year":"2005","unstructured":"Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol. 2005;17(4):359\u201365.","journal-title":"Curr Opin Immunol"},{"issue":"31","key":"1143_CR16","doi-asserted-by":"publisher","first-page":"18581","DOI":"10.1074\/jbc.270.31.18581","volume":"270","author":"K Takahashi","year":"1995","unstructured":"Takahashi K, Paladini RD, Coulombe PA. Cloning and characterization of multiple human genes and cDNAs encoding highly related type II keratin 6 isoforms. J Biol Chem. 1995;270(31):18581\u201392.","journal-title":"J Biol Chem"},{"issue":"1","key":"1143_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.yexcr.2004.08.007","volume":"301","author":"D DePianto","year":"2004","unstructured":"DePianto D, Coulombe PA. Intermediate filaments and tissue repair. Exp Cell Res. 2004;301(1):68\u201376.","journal-title":"Exp Cell Res"},{"issue":"5","key":"1143_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"key":"1143_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109181","volume":"117","author":"X Yuan","year":"2019","unstructured":"Yuan X, Li J, Li Y, Deng Z, Zhou L, Long J, et al. Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea. Biomed Pharmacotherapy. 2019;117: 109181.","journal-title":"Biomed Pharmacotherapy."},{"issue":"4","key":"1143_CR20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/1346-8138.14792","volume":"46","author":"Z Deng","year":"2019","unstructured":"Deng Z, Chen M, Xie H, Jian D, Xu S, Peng Q. Claudin reduction may relate to an impaired skin barrier in rosacea. J Dermatol. 2019;46(4):314\u201321.","journal-title":"J Dermatol"},{"issue":"D1","key":"1143_CR21","doi-asserted-by":"publisher","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","volume":"51","author":"UniProt Consortium","year":"2023","unstructured":"UniProt Consortium. UniProt: the universal protein knowledgebase in 2023. Nucleic Acids Res. 2023;51(D1):D523\u201331.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"1143_CR22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","volume":"19","author":"M Mirdita","year":"2022","unstructured":"Mirdita M, Sch\u00fctze K, Moriwaki Y, Heo L, Ovchinnikov S, Steinegger M. ColabFold: making protein folding accessible to all. Nat Methods. 2022;19(6):679\u201382.","journal-title":"Nat Methods"},{"issue":"7873","key":"1143_CR23","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41586-021-03828-1","volume":"596","author":"K Tunyasuvunakool","year":"2021","unstructured":"Tunyasuvunakool K, Adler J, Wu Z, Green T, Zielinski M, \u017d\u00eddek A, Bridgland A, et al. Highly accurate protein structure prediction for the human proteome. Nature. 2021;596(7873):590\u20136.","journal-title":"Nature"},{"issue":"8","key":"1143_CR24","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nm1616","volume":"13","author":"K Yamasaki","year":"2007","unstructured":"Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007;13(8):975\u201380.","journal-title":"Nat Med"},{"issue":"8","key":"1143_CR25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/exd.13143","volume":"26","author":"AD Holmes","year":"2017","unstructured":"Holmes AD, Steinhoff M. Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics. Exp Dermatol. 2017;26(8):659\u201367.","journal-title":"Exp Dermatol"},{"key":"1143_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102427","volume":"55","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Li Y, Zhou L, Yuan X, Wang Y, Deng Q, et al. Nav1.8 in keratinocytes contributes to ROS-mediated inflammation in inflammatory skin diseases. Redox Biol. 2022;55: 102427.","journal-title":"Redox Biol"},{"issue":"2","key":"1143_CR27","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1167\/iovs.16-20275","volume":"58","author":"EJ Wladis","year":"2017","unstructured":"Wladis EJ, Swamy S, Herrmann A, Yang J, Carlson JA, Adam AP. Activation of p38 and Erk mitogen-activated protein kinases signaling in ocular Rosacea. Invest Ophthalmol Vis Sci. 2017;58(2):843\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1143_CR28","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.2147\/JIR.S356551","volume":"15","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang B, Huang Y, Li Y, Yan S, Xie H, et al. Multi-transcriptomic analysis and experimental validation implicate a central role of STAT3 in skin barrier dysfunction induced aggravation of Rosacea. J Inflamm Res. 2022;15:2141\u201356.","journal-title":"J Inflamm Res"},{"issue":"4","key":"1143_CR29","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1007\/s10753-017-0581-x","volume":"40","author":"X Jiang","year":"2017","unstructured":"Jiang X, Fang L, Wu H, Mei X, He F, Ding P, et al. TLR2 regulates allergic airway inflammation and autophagy through PI3K\/Akt signaling pathway. Inflammation. 2017;40(4):1382\u201392.","journal-title":"Inflammation"},{"issue":"9","key":"1143_CR30","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.celrep.2015.04.049","volume":"11","author":"H Kim","year":"2015","unstructured":"Kim H, Frederick DT, Levesque MP, Cooper ZA, Feng Y, Krepler C, et al. Downregulation of the ubiquitin ligase RNF125 underlies resistance of melanoma cells to BRAF inhibitors via JAK1 deregulation. Cell Rep. 2015;11(9):1458\u201373.","journal-title":"Cell Rep"},{"issue":"6","key":"1143_CR31","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.ymthe.2021.02.018","volume":"29","author":"M Li","year":"2021","unstructured":"Li M, Xu Y, Liang J, Lin H, Qi X, Li F, et al. USP22 deficiency in melanoma mediates resistance to T cells through IFN\u03b3-JAK1-STAT1 signal axis. Mol Therapy J Am Soc Gene Therapy. 2021;29(6):2108\u201320.","journal-title":"Mol Therapy J Am Soc Gene Therapy"},{"issue":"23","key":"1143_CR32","doi-asserted-by":"publisher","first-page":"14843","DOI":"10.1073\/pnas.232580999","volume":"99","author":"XB Qiu","year":"2002","unstructured":"Qiu XB, Goldberg AL. Nrdp1\/FLRF is a ubiquitin ligase promoting ubiquitination and degradation of the epidermal growth factor receptor family member, ErbB3. Proc Natl Acad Sci USA. 2002;99(23):14843\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"1143_CR33","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/ijd.15852","volume":"61","author":"H Cort\u00e9s","year":"2022","unstructured":"Cort\u00e9s H, Rojas-M\u00e1rquez M, Del Prado-Audelo ML, Reyes-Hern\u00e1ndez OD, Gonz\u00e1lez-Del CM. Alterations in mental health and quality of life in patients with skin disorders: a narrative review. Int J Dermatol. 2022;61(7):783\u201391.","journal-title":"Int J Dermatol"},{"issue":"7","key":"1143_CR34","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/ced.13919","volume":"44","author":"V Singam","year":"2019","unstructured":"Singam V, Rastogi S, Patel KR, Lee HH, Silverberg JI. The mental health burden in acne vulgaris and rosacea: an analysis of the US National Inpatient Sample. Clin Exp Dermatol. 2019;44(7):766\u201372.","journal-title":"Clin Exp Dermatol"},{"issue":"48","key":"1143_CR35","doi-asserted-by":"publisher","first-page":"19537","DOI":"10.1073\/pnas.1309576110","volume":"110","author":"JC Lessard","year":"2013","unstructured":"Lessard JC, Pi\u00f1a-Paz S, Rotty JD, Hickerson RP, Kaspar RL, Balmain A, et al. Keratin 16 regulates innate immunity in response to epidermal barrier breach. Proc Natl Acad Sci USA. 2013;110(48):19537\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"1143_CR36","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/ng.665","volume":"42","author":"D Depianto","year":"2010","unstructured":"Depianto D, Kerns ML, Dlugosz AA, Coulombe PA. Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin. Nat Genet. 2010;42(10):910\u20134.","journal-title":"Nat Genet"},{"issue":"24","key":"1143_CR37","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1097\/CM9.0000000000001197","volume":"133","author":"CY Xiao","year":"2020","unstructured":"Xiao CY, Zhu ZL, Zhang C, Fu M, Qiao HJ, Wang G, et al. Small interfering RNA targeting of keratin 17 reduces inflammation in imiquimod-induced psoriasis-like dermatitis. Chin Med J. 2020;133(24):2910\u20138.","journal-title":"Chin Med J"},{"issue":"Pt 22","key":"1143_CR38","first-page":"5269","volume":"125","author":"W Roth","year":"2012","unstructured":"Roth W, Kumar V, Beer HD, Richter M, Wohlenberg C, Reuter U, et al. Keratin 1 maintains skin integrity and participates in an inflammatory network in skin through interleukin-18. J Cell Sci. 2012;125(Pt 22):5269\u201379.","journal-title":"J Cell Sci"},{"issue":"10","key":"1143_CR39","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1038\/jid.2014.197","volume":"134","author":"H Fischer","year":"2014","unstructured":"Fischer H, Langbein L, Reichelt J, Praetzel-Wunder S, Buchberger M, Ghannadan M, et al. Loss of keratin K2 expression causes aberrant aggregation of K10, hyperkeratosis, and inflammation. J Invest Dermatol. 2014;134(10):2579\u201388.","journal-title":"J Invest Dermatol"},{"issue":"12","key":"1143_CR40","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1038\/sj.jid.5700918","volume":"127","author":"H Lu","year":"2007","unstructured":"Lu H, Chen J, Planko L, Zigrino P, Klein-Hitpass L, Magin TM. Induction of inflammatory cytokines by a keratin mutation and their repression by a small molecule in a mouse model for EBS. J Invest Dermatol. 2007;127(12):2781\u20139.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1143_CR41","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1046\/j.0022-202X.2003.22122.x","volume":"122","author":"I Smyth","year":"2004","unstructured":"Smyth I, Ellis T, Hetherington R, Riley E, Narang M, Mahony D, et al. Krt6a-Cre transgenic mice direct LoxP-mediated recombination to the companion cell layer of the hair follicle and following induction by retinoic acid to the interfollicular epidermis. J Invest Dermatol. 2004;122(1):232\u20134.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1143_CR42","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/s42003-022-04232-9","volume":"5","author":"SY An","year":"2022","unstructured":"An SY, Kim HS, Kim SY, Van SY, Kim HJ, Lee JH, et al. Keratin-mediated hair growth and its underlying biological mechanism. Commun Biol. 2022;5(1):1270.","journal-title":"Commun Biol"},{"issue":"33","key":"1143_CR43","doi-asserted-by":"publisher","first-page":"7878","DOI":"10.1523\/JNEUROSCI.0315-17.2017","volume":"37","author":"DS Tian","year":"2017","unstructured":"Tian DS, Peng J. Chemokine CCL2-CCR2 signaling induces neuronal cell death via STAT3 activation and IL-1\u03b2 production after status epilepticus. J Neurosci. 2017;37(33):7878\u201392.","journal-title":"J Neurosci"},{"key":"1143_CR44","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/1471-2407-8-302","volume":"8","author":"JC Lieblein","year":"2008","unstructured":"Lieblein JC, Ball S, Hutzen B, Sasser AK, Lin HJ, Huang TH, et al. STAT3 can be activated through paracrine signaling in breast epithelial cells. BMC Cancer. 2008;8:302.","journal-title":"BMC Cancer"},{"key":"1143_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bbrc.2022.05.004","volume":"613","author":"JH Yun","year":"2022","unstructured":"Yun JH, Lee DH, Jeong HS, Kim SH, Ye SK, Cho CH. STAT3 activation in microglia increases pericyte apoptosis in diabetic retinas through TNF-\u0251\/AKT\/p70S6 kinase signaling. Biochem Biophys Res Commun. 2022;613:133\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"1143_CR46","first-page":"1145","volume":"31","author":"C Chen","year":"2022","unstructured":"Chen C, Yang Z, Yin X, Huang S, Yan J, Sun Q. CircEIF5 contributes to hyperproliferation and inflammation of keratinocytes in psoriasis via p-NF\u03baB and p-STAT3 signalling pathway. Exp Dermatol. 2022;31(8):1145\u201353.","journal-title":"Exp Dermatol"},{"key":"1143_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28020","author":"MJ Lee","year":"2023","unstructured":"Lee MJ, Lee J, Kang SK, Wirth D, Yoo SM, Park C, et al. CXCL1 confers a survival advantage in Kaposi\u2019s sarcoma-associated herpesvirus-infected human endothelial cells through STAT3 phosphorylation. J Med Virol. 2023. https:\/\/doi.org\/10.1002\/jmv.28020.","journal-title":"J Med Virol"},{"issue":"2","key":"1143_CR48","doi-asserted-by":"publisher","first-page":"986","DOI":"10.4049\/jimmunol.178.2.986","volume":"178","author":"CH Yang","year":"2007","unstructured":"Yang CH, Wei L, Pfeffer SR, Du Z, Murti A, Valentine WJ, et al. Identification of CXCL11 as a STAT3-dependent gene induced by IFN. J Immunol (Baltimore, Md: 1950). 2007;178(2):986\u201392.","journal-title":"J Immunol (Baltimore, Md: 1950)."},{"issue":"5","key":"1143_CR49","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101458R","volume":"36","author":"P Qiao","year":"2022","unstructured":"Qiao P, Zhi D, Yu C, Zhang C, Wu K, Fang H, et al. Activation of the C3a anaphylatoxin receptor inhibits keratinocyte proliferation by regulating keratin 6, keratin 16, and keratin 17 in psoriasis. FASEB J. 2022;36(5): e22322.","journal-title":"FASEB J"},{"issue":"1","key":"1143_CR50","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jid.2021.05.033","volume":"142","author":"X Dai","year":"2022","unstructured":"Dai X, Shiraishi K, Muto J, Utsunomiya R, Mori H, Murakami M, et al. Nuclear IL-33 plays an important role in IL-31-mediated downregulation of FLG, Keratin 1, and Keratin 10 by regulating signal transducer and activator of transcription 3 activation in human keratinocytes. J Invest Dermatol. 2022;142(1):136-44.e3.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"1143_CR51","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jdermsci.2018.02.017","volume":"90","author":"WI Ryu","year":"2018","unstructured":"Ryu WI, Lee H, Bae HC, Jeon J, Ryu HJ, Kim J, et al. IL-33 down-regulates CLDN1 expression through the ERK\/STAT3 pathway in keratinocytes. J Dermatol Sci. 2018;90(3):313\u201322.","journal-title":"J Dermatol Sci"},{"issue":"3","key":"1143_CR52","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jaci.2015.03.051","volume":"136","author":"W Amano","year":"2015","unstructured":"Amano W, Nakajima S, Kunugi H, Numata Y, Kitoh A, Egawa G, et al. The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling. J Allergy Clin Immunol. 2015;136(3):667-77.e7.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"1143_CR53","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1016\/j.jid.2018.05.016","volume":"138","author":"L Yang","year":"2018","unstructured":"Yang L, Jin L, Ke Y, Fan X, Zhang T, Zhang C, et al. E3 ligase Trim21 ubiquitylates and stabilizes Keratin 17 to induce STAT3 activation in psoriasis. J Invest Dermatol. 2018;138(12):2568\u201377.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"1143_CR54","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/bjd.14018","volume":"173","author":"KA Papp","year":"2015","unstructured":"Papp KA, Menter MA, Abe M, Elewski B, Feldman SR, Gottlieb AB, et al. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials. Br J Dermatol. 2015;173(4):949\u201361.","journal-title":"Br J Dermatol"},{"issue":"11","key":"1143_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15848","volume":"35","author":"YH Sun","year":"2022","unstructured":"Sun YH, Man XY. Tofacitinib for the treatment of erythematotelangiectatic and papulopustular rosacea: a retrospective case series. Dermatol Ther. 2022;35(11): e15848.","journal-title":"Dermatol Ther"},{"issue":"6467","key":"1143_CR56","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.aax3769","volume":"366","author":"C Pohl","year":"2019","unstructured":"Pohl C, Dikic I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science (New York, NY). 2019;366(6467):818\u201322.","journal-title":"Science (New York, NY)"},{"issue":"Pt 6","key":"1143_CR57","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1242\/jcs.078055","volume":"124","author":"J Wauman","year":"2011","unstructured":"Wauman J, De Ceuninck L, Vanderroost N, Lievens S, Tavernier J. RNF41 (Nrdp1) controls type 1 cytokine receptor degradation and ectodomain shedding. J Cell Sci. 2011;124(Pt 6):921\u201332.","journal-title":"J Cell Sci"},{"issue":"6","key":"1143_CR58","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1002\/jcb.28178","volume":"120","author":"Y Xu","year":"2019","unstructured":"Xu Y, Liang C. Possible mechanism of GATA4 inhibiting myocardin activity during cardiac hypertrophy. J Cell Biochem. 2019;120(6):9047\u201355.","journal-title":"J Cell Biochem"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-025-01143-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-025-01143-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-025-01143-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T20:01:43Z","timestamp":1746820903000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-025-01143-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1143"],"URL":"https:\/\/doi.org\/10.1186\/s12929-025-01143-9","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"24 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethical committee of the Xiangya Hospital of Central South University (IRB number 202203076), and all subjects obtained written informed consent. All animals were purchased from Slack Company (Shanghai, China) and comply with the National Research Council\u2019s Guide for the Care and Use of Laboratory Animals (IRB No. 2022020368).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}